Suppr超能文献

儿童颞骨肥大细胞肉瘤伴新型 L799F(2395C>T)KIT 突变,类似组织细胞肿瘤。

Pediatric mast cell sarcoma of temporal bone with novel L799F (2395 C>T) KIT mutation, mimicking histiocytic neoplasm.

机构信息

Department of Pathology, City of Hope National Medical Center, Duarte, CA 91010, USA.

出版信息

Am J Surg Pathol. 2013 Mar;37(3):453-8. doi: 10.1097/PAS.0b013e31828446d6.

Abstract

Mast cell sarcoma (MCS) is an extremely rare neoplasm with a clinically aggressive course. Because of its rarity, its morphologic and molecular characteristics are still not well defined. We report a case of a 15-year-old girl with MCS of the temporal bone extending into the posterior fossa creating a mass effect. The lesion mimicked a histiocytic neoplasm morphologically, but showed a novel KIT missense mutation, L799F (2395 C>T). The KIT D816V mutation is frequently found in systemic mastocytosis, but it has not been documented in the few reported human MCS cases. However, 1 reported case of MCS has shown a different alteration in the KIT gene. Our case is the first MCS case with L799F mutation, located between the catalytic loop (790 to 797) and the activation loop (810 to 837) of the KIT gene, and only the second case of MCS with KIT mutation documented in the literature. Proximity of the L799F mutation to the enzymatic region of the KIT tyrosine kinase domain may induce resistance to tyrosine kinase inhibitors.

摘要

肥大细胞瘤肉瘤(MCS)是一种极其罕见的具有临床侵袭性病程的肿瘤。由于其罕见性,其形态和分子特征仍未得到很好的定义。我们报告了一例 15 岁女孩的颞骨 MCS 延伸至后颅窝,产生肿块效应。病变在形态上类似于组织细胞肿瘤,但显示出一种新的 KIT 错义突变,L799F(2395C>T)。KIT D816V 突变在系统性肥大细胞增多症中经常发现,但在少数报道的人类 MCS 病例中尚未记录。然而,有 1 例 MCS 报告显示 KIT 基因发生了不同的改变。我们的病例是首例 L799F 突变的 MCS 病例,位于 KIT 基因的催化环(790 至 797)和激活环(810 至 837)之间,也是文献中第二例有 KIT 突变记录的 MCS 病例。L799F 突变靠近 KIT 酪氨酸激酶结构域的酶区域,可能诱导对酪氨酸激酶抑制剂的耐药性。

相似文献

2
Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis?
Pathol Res Pract. 2012 Nov 15;208(11):683-6. doi: 10.1016/j.prp.2012.06.010. Epub 2012 Sep 7.
3
Mast cell sarcoma in an infant: a case report and review of the literature.
J Pediatr Hematol Oncol. 2013 May;35(4):315-20. doi: 10.1097/MPH.0b013e318279e392.
4
Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
Pathol Res Pract. 2007;203(3):127-34. doi: 10.1016/j.prp.2006.12.005. Epub 2007 Feb 12.
5
Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature.
J Clin Oncol. 2013 Feb 20;31(6):e90-7. doi: 10.1200/JCO.2012.41.9549. Epub 2012 Nov 5.
7
Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.
Eur J Haematol. 2012 Jul;89(1):47-52. doi: 10.1111/j.1600-0609.2012.01761.x. Epub 2012 Apr 28.

引用本文的文献

1
Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.
Int J Mol Sci. 2021 Mar 4;22(5):2586. doi: 10.3390/ijms22052586.
2
Mast cell sarcoma of the sternum, clonally related to an antecedent germ cell tumor with a novel D579del KIT mutation.
Virchows Arch. 2017 May;470(5):583-588. doi: 10.1007/s00428-017-2089-z. Epub 2017 Feb 24.
3
Mast cell sarcoma: new cases and literature review.
Oncotarget. 2016 Oct 4;7(40):66299-66309. doi: 10.18632/oncotarget.11812.
4
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.
Leukemia. 2015 Jun;29(6):1223-32. doi: 10.1038/leu.2015.24. Epub 2015 Feb 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验